메뉴 건너뛰기




Volumn 65, Issue 10, 2011, Pages 1076-1084

Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure

Author keywords

[No Author keywords available]

Indexed keywords

GLIMEPIRIDE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; SULFONYLUREA;

EID: 80053022273     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02755.x     Document Type: Article
Times cited : (20)

References (31)
  • 1
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group.
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 2
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, et al., Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-17.
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3
  • 3
    • 33947408052 scopus 로고    scopus 로고
    • Why, when and how to initiate insulin therapy in patients with type 2 diabetes
    • DOI 10.1111/j.1742-1241.2007.01309.x
    • Tibaldi J, Rakel RE,. Why, when and how to initiate insulin therapy in patients with type 2 diabetes. Int J Clin Pract 2007; 61: 633-44. (Pubitemid 46449825)
    • (2007) International Journal of Clinical Practice , vol.61 , Issue.4 , pp. 633-644
    • Tibaldi, J.1    Rakel, R.E.2
  • 4
    • 84856623197 scopus 로고    scopus 로고
    • Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in Korean drug-naïve type 2 diabetic patients: The practical evidence of antidiabetic monotherapy study
    • Yoon KH, Shin JA, Kwon HS, et al., Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in Korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy study. Diabetes Metab J 2011; 35: 26-33.
    • (2011) Diabetes Metab J , vol.35 , pp. 26-33
    • Yoon, K.H.1    Shin, J.A.2    Kwon, H.S.3
  • 5
    • 0022544897 scopus 로고
    • Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes
    • Groop LC, Pelkonen R, Koskimies S, et al., Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care 1986; 9: 129-33. (Pubitemid 16080466)
    • (1986) Diabetes Care , vol.9 , Issue.2 , pp. 129-133
    • Groop, L.C.1    Pelkonen, R.2    Koskimies, S.3
  • 6
    • 0036483958 scopus 로고    scopus 로고
    • Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)
    • DOI 10.2337/diacare.25.2.330
    • Wright A, Burden AC, Paisey RB, et al., Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002; 25: 330-6. (Pubitemid 41079631)
    • (2002) Diabetes Care , vol.25 , Issue.2 , pp. 330-336
    • Wright, A.1    Burden, A.C.F.2    Paisey, R.B.3    Cull, C.A.4    Holman, R.R.5
  • 7
    • 0025630035 scopus 로고
    • Insulin use in NIDDM
    • Genuth S,. Insulin use in NIDDM. Diabetes Care 1990; 13: 1240-64.
    • (1990) Diabetes Care , vol.13 , pp. 1240-1264
    • Genuth, S.1
  • 9
    • 70349939595 scopus 로고    scopus 로고
    • Practical guidance on intensification of insulin therapy with BIAsp 30: A consensus statement
    • Unnikrishnan AG, Tibaldi J, Hadley-Brown M, et al., Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement. Int J Clin Pract 2009; 63: 1571-7.
    • (2009) Int J Clin Pract , vol.63 , pp. 1571-1577
    • Unnikrishnan, A.G.1    Tibaldi, J.2    Hadley-Brown, M.3
  • 10
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
    • DOI 10.1007/BF00280883
    • Matthews DR, Hosker JP, Rudenski AS, et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9. (Pubitemid 15018832)
    • (1985) Diabetologia , vol.28 , Issue.7 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3
  • 11
    • 28444436268 scopus 로고    scopus 로고
    • Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy
    • Lee BW, Kang HW, Heo JS, et al., Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy. Metabolism 2006; 55: 135-41.
    • (2006) Metabolism , vol.55 , pp. 135-141
    • Lee, B.W.1    Kang, H.W.2    Heo, J.S.3
  • 12
    • 61849106040 scopus 로고    scopus 로고
    • Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels
    • Utzschneider KM, Prigeon RL, Faulenbach MV, et al., Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32: 335-41.
    • (2009) Diabetes Care , vol.32 , pp. 335-341
    • Utzschneider, K.M.1    Prigeon, R.L.2    Faulenbach, M.V.3
  • 13
    • 0029384730 scopus 로고
    • The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion
    • Wareham NJ, Phillips DI, Byrne CD, Hales CN,. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 1995; 12: 931.
    • (1995) Diabet Med , vol.12 , pp. 931
    • Wareham, N.J.1    Phillips, D.I.2    Byrne, C.D.3    Hales, C.N.4
  • 14
    • 19444376266 scopus 로고    scopus 로고
    • Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus
    • DOI 10.1592/phco.2005.25.6.810
    • Eurich DT, Simpson SH, Majumdar SR, Johnson JA,. Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus. Pharmacotherapy 2005; 25: 810-6. (Pubitemid 40727132)
    • (2005) Pharmacotherapy , vol.25 , Issue.6 , pp. 810-816
    • Eurich, D.T.1    Simpson, S.H.2    Majumdar, S.R.3    Johnson, J.A.4
  • 15
    • 0035340319 scopus 로고    scopus 로고
    • Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus
    • Kim DJ, Lee MS, Kim KW, Lee MK,. Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus. Metabolism 2001; 50: 590-3.
    • (2001) Metabolism , vol.50 , pp. 590-593
    • Kim, D.J.1    Lee, M.S.2    Kim, K.W.3    Lee, M.K.4
  • 16
    • 23944458639 scopus 로고    scopus 로고
    • Heterogeneity of early-onset and ketosis-resistant diabetes in Korean subjects - Is it possible to determine cut-off age of early-onset type 2 diabetes?
    • Lee BW, Kim SY, Kim JY, et al., Heterogeneity of early-onset and ketosis-resistant diabetes in Korean subjects-is it possible to determine cut-off age of early-onset type 2 diabetes? Diabetes Res Clin Pract 2005; 70: 38-45.
    • (2005) Diabetes Res Clin Pract , vol.70 , pp. 38-45
    • Lee, B.W.1    Kim, S.Y.2    Kim, J.Y.3
  • 17
    • 77956628848 scopus 로고    scopus 로고
    • Dysfunctional pancreatic beta-cells of critical stress play a more prominent role in the development of stress diabetes in critically burned Korean subjects
    • Byung-Wan L, Jun H, Yim HJ, et al., Dysfunctional pancreatic beta-cells of critical stress play a more prominent role in the development of stress diabetes in critically burned Korean subjects. Metabolism 2010; 59: 1307-15.
    • (2010) Metabolism , vol.59 , pp. 1307-1315
    • Byung-Wan, L.1    Jun, H.2    Yim, H.J.3
  • 18
    • 80053039032 scopus 로고    scopus 로고
    • The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects
    • Rhee SY, Kim JY, Chon S, et al., The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects. Korean Diabetes J 2010; 34: 157-65.
    • (2010) Korean Diabetes J , vol.34 , pp. 157-165
    • Rhee, S.Y.1    Kim, J.Y.2    Chon, S.3
  • 19
    • 23644443235 scopus 로고    scopus 로고
    • Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: Effects of lifestyle intervention and metformin
    • DOI 10.2337/diabetes.54.8.2404
    • Kitabchi AE, Temprosa M, Knowler WC, et al., Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005; 54: 2404-14. (Pubitemid 41134269)
    • (2005) Diabetes , vol.54 , Issue.8 , pp. 2404-2414
    • Kitabchi, A.E.1
  • 20
    • 77955468245 scopus 로고    scopus 로고
    • Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes
    • Kayaniyil S, Vieth R, Retnakaran R, et al., Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010; 33: 1379-81.
    • (2010) Diabetes Care , vol.33 , pp. 1379-1381
    • Kayaniyil, S.1    Vieth, R.2    Retnakaran, R.3
  • 21
    • 70549111807 scopus 로고    scopus 로고
    • Evaluation of proposed oral disposition index measures in relation to the actual disposition index
    • Retnakaran R, Qi Y, Goran MI, Hamilton JK,. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 2009; 26: 1198-203.
    • (2009) Diabet Med , vol.26 , pp. 1198-1203
    • Retnakaran, R.1    Qi, Y.2    Goran, M.I.3    Hamilton, J.K.4
  • 22
    • 0036318476 scopus 로고    scopus 로고
    • Accurate assessment of β-cell function: The hyperbolic correction
    • Bergman RN, Ader M, Huecking K, Van Citters G,. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002; 51 (Suppl 1): S212-20. (Pubitemid 34761518)
    • (2002) Diabetes , vol.51 , Issue.SUPPL.
    • Bergman, R.N.1    Ader, M.2    Huecking, K.3    Van Citters, G.4
  • 23
    • 12844265257 scopus 로고    scopus 로고
    • Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs
    • DOI 10.2337/diacare.28.2.260
    • Raskin P, Allen E, Hollander P, et al., Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005; 28: 260-5. (Pubitemid 40170923)
    • (2005) Diabetes Care , vol.28 , Issue.2 , pp. 260-265
    • Raskin, P.1    Allen, E.2    Hollander, P.3    Lewin, A.4    Gabbay, R.A.5    Hu, P.6    Bode, B.7    Garber, A.8
  • 24
    • 14844360413 scopus 로고    scopus 로고
    • Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
    • DOI 10.1016/j.clinthera.2004.12.015
    • Malone JK, Kerr LF, Campaigne BN, et al., Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy. Clin Ther 2004; 26: 2034-44. (Pubitemid 40353613)
    • (2004) Clinical Therapeutics , vol.26 , Issue.12 , pp. 2034-2044
    • Malone, J.K.1    Kerr, L.F.2    Campaigne, B.N.3    Sachson, R.A.4    Holcombe, J.H.5
  • 25
    • 33646014162 scopus 로고    scopus 로고
    • Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)
    • Garber AJ, Wahlen J, Wahl T, et al., Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab 2006; 8: 58-66.
    • (2006) Diabetes Obes Metab , vol.8 , pp. 58-66
    • Garber, A.J.1    Wahlen, J.2    Wahl, T.3
  • 26
    • 58149203398 scopus 로고    scopus 로고
    • Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: A subgroup analysis of the PRESENT Korea NovoMixstudy
    • Jang HC, Lee SR, Vaz JA,. Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMixstudy. Diabetes Obes Metab 2009; 11: 20-6.
    • (2009) Diabetes Obes Metab , vol.11 , pp. 20-26
    • Jang, H.C.1    Lee, S.R.2    Vaz, J.A.3
  • 27
    • 77955093018 scopus 로고    scopus 로고
    • Evaluation of error levels in hemoglobin A1c and glycated albumin in type 2 diabetic patients due to inter-individual variability
    • Tahara Y, Shima K,. Evaluation of error levels in hemoglobin A1c and glycated albumin in type 2 diabetic patients due to inter-individual variability. Diabetes Res Clin Pract 2010; 89: 115-20.
    • (2010) Diabetes Res Clin Pract , vol.89 , pp. 115-120
    • Tahara, Y.1    Shima, K.2
  • 28
    • 33947605228 scopus 로고    scopus 로고
    • Comparison of Glycated Albumin (GA) and Glycated Hemoglobin (HbA1c) in type 2 diabetic patients: Usefulness of GA for evaluation of short-term changes in glycemic control
    • DOI 10.1507/endocrj.K06-103
    • Takahashi S, Uchino H, Shimizu T, et al., Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007; 54: 139-44. (Pubitemid 46481682)
    • (2007) Endocrine Journal , vol.54 , Issue.1 , pp. 139-144
    • Takahashi, S.1    Uchino, H.2    Shimizu, T.3    Kanazawa, A.4    Tamura, Y.5    Sakai, K.6    Watada, H.7    Hirose, T.8    Kawamori, R.9    Tanaka, Y.10
  • 29
    • 75149140141 scopus 로고    scopus 로고
    • Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes
    • Koga M, Murai J, Saito H, Kasayama S,. Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes. Diabetes Care 2010; 33: 270-2.
    • (2010) Diabetes Care , vol.33 , pp. 270-272
    • Koga, M.1    Murai, J.2    Saito, H.3    Kasayama, S.4
  • 31
    • 79960253676 scopus 로고    scopus 로고
    • Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients
    • Lee EY, Lee BY, Kim D, et al., Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol 2011; 48: 167-72.
    • (2011) Acta Diabetol , vol.48 , pp. 167-172
    • Lee, E.Y.1    Lee, B.Y.2    Kim, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.